Original articles, written in-house and citing our sources, on news relevant to Atumio's active case types.
Meta agreed to pay up to $16.7 billion and adopt new teen-safety limits to settle a multistate social media addiction case, cutting short a trial that had just opened in Oakland federal court.
Read more →Senators Hawley and Durbin opened a formal child-safety investigation into Roblox in mid-August 2026, the same week Ohio's attorney general moved to lead a securities class action alleging the company misled investors about its safety measures.
Read more →Nearly 2,000 Lyft passenger sexual assault cases are coordinated in California state court, with the first bellwether trial set for September 30, 2026 — a separate track from the roughly 4,400 similar lawsuits pending against Uber.
Read more →A Chicago couple filed the first Illinois lawsuit over the 2026 Cyclospora lettuce outbreak on August 21, 2026, as the CDC and FDA put the nationwide case count at 10,930 illnesses across 17 states, with 454 hospitalizations and two deaths.
Read more →A St. Louis jury ruled for Mead Johnson on July 6, 2026 in a state-court trial over whether its Enfamil preterm formula caused an infant's necrotizing enterocolitis, a defense win as nearly 1,000 similar cases move through state and federal courts.
Read more →Families are suing AI chatbot makers including Character.AI, Google, and OpenAI over deaths and injuries linked to chatbot interactions, and Florida has filed the first state lawsuit against OpenAI.
Read more →Washington's Attorney General opened trial against Albertsons on July 13, 2026, alleging its pharmacies dispensed more than 641 million opioid pills despite unresolved red flags between 2006 and 2022.
Read more →Federal juries sided with plaintiffs in both Uber passenger sexual assault bellwether trials held so far in 2026, and a judge ruled Uber is a common carrier, ahead of the next trials set for September.
Read more →The JPML created MDL No. 3181 for Boston Scientific spinal cord stimulator lawsuits on June 5, 2026, centralizing 23 device-failure cases in the Central District of California.
Read more →The JPML centralized ByHeart infant formula botulism lawsuits into MDL No. 3178 in the Southern District of New York on April 2, 2026, following a nationwide recall tied to an infant botulism outbreak.
Read more →Camp Lejeune settlement offers have surpassed $1 billion and payouts have topped $827 million, as the DOJ approved $175 million in new settlements over a recent three-week stretch.
Read more →The first federal bellwether trial against Mead Johnson's Enfamil opened August 12, 2026, the start of a second wave of NEC baby formula trials scheduled through early 2027.
Read more →The Judicial Panel on Multidistrict Litigation centralized federal Dupixent T-cell lymphoma lawsuits into MDL No. 3180 in New Jersey on June 4, 2026, consolidating 15 transferred cases before Judge Zahid N. Quraishi.
Read more →Chief Judge Renée Marie Bumb gave final approval on August 7, 2026 to more than $2.5 billion in New Jersey PFAS settlements with DuPont, Chemours, Corteva, and 3M, including a $1.2 billion restoration fund.
Read more →The JPML created MDL No. 3196 on August 1, 2026 for lawsuits over a Cyclospora outbreak traced to Taylor Farms iceberg lettuce, which the CDC says has sickened more than 6,300 people across 15 states.
Read more →The SSA added 14 new conditions to its Compassionate Allowances list on August 11, 2026, letting people with those diagnoses get SSDI decisions faster.
Read more →A New Mexico judge ordered Meta to pay $567 million into a youth mental health treatment and prevention fund on August 6, 2026, bringing the company's total exposure in the state's case to $942 million.
Read more →The California Supreme Court ruled 6-1 on August 3, 2026 that Gilead owed no duty to speed a safer HIV drug to market, resolving one theory in the Gilead Tenofovir Cases while separate failure-to-warn claims from roughly 26,000 TDF/Truvada plaintiffs continue.
Read more →Uniroyal Holding and its Great Hill Corporation subsidiary filed Chapter 11 bankruptcy on July 31, 2026 in New Jersey to resolve more than 35,000 pending asbestos injury claims through a negotiated trust plan.
Read more →A catheter-fracture case survived summary judgment on July 27, 2026 and is set to become the second Bard PowerPort MDL bellwether trial, beginning August 18, 2026, after the first trial ended in a split verdict.
Read more →A Missouri court delayed the final approval hearing for Bayer's $7.25 billion Roundup settlement to September 14, giving more time to resolve opt-out disputes.
Read more →A federal jury in Boston ordered Medtronic to pay $88 million on August 4, 2026 over its Covidien unit's Symbotex hernia mesh, the largest verdict yet in the hernia mesh litigation and the outcome of the first Covidien bellwether trial.
Read more →A Cook County jury awarded $53 million in compensatory damages, plus $17 million in punitive damages, on April 9, 2026 to four mothers whose premature infants developed NEC after being fed Abbott's Similac Special Care 24 formula.
Read more →Johnson & Johnson has proposed a $5.5 billion settlement to resolve roughly 76,000 remaining talcum powder lawsuits, its fourth attempt to close out the litigation after three failed bankruptcy maneuvers.
Read more →A new case management order in the federal paraquat MDL requires plaintiffs who didn't accept the settlement offer to produce detailed proof of exposure, diagnosis, and causation, or risk dismissal.
Read more →The D.C. Court of Appeals denied Meta's attempt to shield internal youth-wellbeing research from discovery in a consumer-protection lawsuit, letting document production continue.
Read more →A Delaware court dismissed more than 80,000 Zantac cancer lawsuits against Boehringer Ingelheim in April 2026 over expert testimony standards — but cases against other manufacturers, and in other states, are still moving forward.
Read more →A Missouri appeals court upheld a $495 million jury verdict against Abbott Laboratories in a preterm infant formula NEC case, rejecting the company's bid to overturn the award and clearing the way for a possible Missouri Supreme Court appeal.
Read more →The Social Security Administration marked SSDI's 70th anniversary on August 1, 2026, reporting initial disability decisions now arrive 40 days faster than in January 2025.
Read more →A Missouri judge set August 19, 2026 as the new final approval hearing date for Bayer's $7.25 billion Roundup class settlement, following objections and a favorable Supreme Court ruling for Bayer.
Read more →A California jury awarded $966 million to the family of an 88-year-old woman who died of mesothelioma linked to decades of Johnson & Johnson talc-based baby powder use.
Read more →A New Mexico jury found Meta misled users about platform safety and put children at risk, ordering the company to pay $375 million — a separate verdict from the March 2026 Meta/YouTube case.
Read more →The federal paraquat MDL has paused individual case preparations while the court considers approving a Qualified Settlement Fund — a concrete step toward actually distributing settlement money.
Read more →DuPont agreed to pay $27 million to resolve nearly a decade of litigation over PFOA water contamination in Hoosick Falls, New York, linked to a nearby Teflon manufacturing site.
Read more →The first federal Enfamil bellwether trial began July 6, 2026, brought by a father whose son died days after birth — a pivotal early test of how juries respond to the NEC baby formula claims.
Read more →The Social Security Administration announced new self-service tools on July 21, 2026 — including a Claim Status Tracker and online document submission — aimed at giving SSDI applicants more visibility into their case.
Read more →A Texas judge rejected Kenvue's motion to dismiss Attorney General Ken Paxton's consumer-protection lawsuit over Tylenol's autism warnings — a separate legal track from the federal personal-injury MDL.
Read more →California, Colorado, Kentucky, and New Jersey are set to try their case against Meta on August 12, 2026, seeking massive civil penalties over allegedly addictive platform design aimed at kids.
Read more →Vermont signed a first-in-the-nation ban on the herbicide paraquat into law on May 26, 2026, citing mounting scientific evidence and thousands of pending Parkinson's disease lawsuits.
Read more →In December 2025, the FDA approved new label language warning that Depo-Provera use is linked to meningioma brain tumors, reversing an earlier decision that had rejected Pfizer's own request for the warning in 2024.
Read more →In February 2025, the federal judicial panel consolidated Depo-Provera meningioma lawsuits into a new multidistrict litigation in Florida, and filings have grown from 27 cases to thousands within about a year.
Read more →After falling from about 350,000 to roughly 270,000 pending hearings in early 2025, the Social Security Administration's disability hearing backlog has climbed back to about 330,000 cases in 2026, extending wait times for claimants.
Read more →The 2026 Substantial Gainful Activity limit, Trial Work Period threshold, and work-credit earnings requirement all increased this year, and a new law expanded ABLE savings account eligibility to millions more disabled Americans.
Read more →The Social Security Administration's 2.8% cost-of-living adjustment took effect in January 2026, raising the average SSDI payment by about $44 a month, though a rising Medicare Part B premium offsets some of that gain for many beneficiaries.
Read more →The first bellwether trial against Covidien over its Symbotex hernia mesh began July 13, 2026 in Boston after a federal judge rejected the company's request to throw out the case, testing claims from more than 2,200 consolidated lawsuits.
Read more →Becton Dickinson's 2024 hernia mesh settlement set up a points-based payout system, but portal problems and a multi-year distribution timeline mean many of the roughly 38,000 claimants are still waiting to get paid in 2026.
Read more →Becton Dickinson announced in October 2024 it would pay more than $1 billion to resolve over 38,000 lawsuits alleging its Bard and Davol hernia mesh products caused organ damage and chronic pain, a deal still shaping the litigation landscape in 2026.
Read more →Bayer's proposed $7.25 billion Roundup class settlement headed to a July 9, 2026 fairness hearing facing more than 100 objections over its opt-out process, attorney fees, and a novel future-claimants subclass.
Read more →In a 7-2 ruling in Monsanto Co. v. Durnell, the Supreme Court held federal pesticide law preempts state failure-to-warn claims requiring a cancer warning EPA hasn't approved — reshaping the landscape for pending Roundup lawsuits.
Read more →A Cobb County, Georgia jury ordered Bayer's Monsanto unit to pay $2.1 billion, including $2 billion in punitive damages, to a man who developed non-Hodgkin lymphoma after two decades of Roundup use.
Read more →A December 2024 dismissal by a federal judge sidelined more than 500 Tylenol autism/ADHD lawsuits for over a year and a half. Here's what that ruling said and why it mattered.
Read more →The Second Circuit has reversed a ruling that gutted the federal Tylenol autism/ADHD litigation, reviving more than 500 cases. Here's what the decision means and what happens next.
Read more →The FDA moved to add an autism/ADHD warning to acetaminophen labels in September 2025. Kenvue's most recent label update, in May 2026, still doesn't include one. Here's the timeline.
Read more →Chemours has agreed to a $450 million settlement with the DOJ and EPA over Clean Water Act violations at three PFAS-producing plants — the first federal enforcement settlement of its kind.
Read more →DuPont, Chemours, and Corteva agreed to pay New Jersey $875 million over 25 years to resolve PFAS contamination claims at four industrial sites, plus fund a remediation reserve of up to $1.2 billion.
Read more →A federal judge has approved agreements clearing the way for New Jersey's PFAS settlements with 3M and DuPont-affiliated companies to move forward, after counties and water authorities dropped objections.
Read more →A Florida teen dropped his social media addiction claims against Meta the day after Snap tentatively settled, canceling a second bellwether trial. Here's what it means for the broader litigation.
Read more →A Los Angeles jury found Meta and YouTube liable for a young woman's social media addiction and awarded $6 million, one of the first verdicts to hold platforms liable for design rather than content.
Read more →TikTok reached a confidential settlement in July 2026 with a plaintiff who alleged the platform's design fueled his social media addiction as a child, avoiding the second bellwether trial in the California litigation.
Read more →A federal judge ordered a special master to help paraquat Parkinson's plaintiffs evaluate settlement offers as the MDL's global settlement framework moves toward payouts.
Read more →Syngenta says it will cease global paraquat production by June 2026, closing its only active-ingredient plant, as advocacy groups tie the move to litigation and state bans.
Read more →Syngenta settled the first paraquat Parkinson's bellwether trial the night before opening statements in Philadelphia, avoiding a jury verdict on causation.
Read more →A new federal MDL now consolidates lawsuits claiming Ozempic and other GLP-1 drugs caused NAION, a rare form of sudden vision loss, in a track separate from existing gastroparesis claims.
Read more →The judge overseeing the Ozempic gastroparesis MDL ruled that claims must be backed by an objective gastric emptying study, not just reported symptoms, raising the evidentiary bar litigation-wide.
Read more →The FDA revised Ozempic's prescribing label in January 2025 to warn about severe gastrointestinal adverse reactions, though plaintiffs' attorneys say it still doesn't fully warn of gastroparesis risk.
Read more →The federal AFFF firefighting foam MDL has grown to more than 23,000 pending cases, but a global personal-injury settlement still hasn't materialized as of mid-2026.
Read more →The first AFFF personal-injury bellwether trial, set for October 2025, was postponed after the court uncovered a backlog of unfiled cases, triggering a filing window and a surge of new claims.
Read more →A federal court gave final approval in 2024 to 3M's up-to-$10.3 billion settlement with public water utilities over PFAS contamination linked to AFFF firefighting foam, a track separate from personal-injury claims.
Read more →The Camp Lejeune Justice Act's filing deadline closed on August 10, 2024, with over 500,000 claims already on file with the Navy. That backlog is still shaping how long claimants are waiting today.
Read more →A June 2026 update shows fewer than 2% of Camp Lejeune Elective Option claims with basic documentation have enough proof to reach the Department of Justice for approval. Here's what's causing the bottleneck.
Read more →A February 2026 court filing shows the court-appointed Camp Lejeune settlement masters held direct mediation sessions with the DOJ and are building a settlement matrix — but no dollar terms have been set yet.
Read more →A February 2026 case management order in the hair relaxer cancer MDL lays out a 90-day window for a deceased plaintiff's family or estate to formally take over her lawsuit. Here's how the process works.
Read more →A unanimous October 2025 Georgia Supreme Court ruling rejected a 'one and done' time-bar defense in a hair relaxer injury case, holding the state's 10-year statute of repose applies separately to each product sold.
Read more →On June 5, 2026, the federal judge overseeing the hair relaxer cancer MDL reappointed 38 plaintiffs' attorneys to leadership roles as the litigation, now covering thousands of women, moves toward bellwether trial selection.
Read more →In February 2024, the Judicial Panel on Multidistrict Litigation consolidated Suboxone film tooth decay lawsuits into MDL 3092 in the Northern District of Ohio — the foundational event behind today's growing litigation against Indivior.
Read more →In February 2026, the Suboxone MDL judge randomly selected 100 cases for a Core Discovery Pool that will be narrowed further ahead of the litigation's first bellwether trials. Here's how the process works.
Read more →In June 2026, the judge overseeing the Suboxone tooth decay MDL compelled outstanding record production and set a July 1, 2026 contempt hearing for non-compliant providers, as the case against Indivior tops 17,900 claims.
Read more →Pfizer has reached a tentative framework to resolve thousands of federal Depo-Provera meningioma lawsuits — but state court cases, including hundreds in Delaware, are on a separate track and unaffected by it.
Read more →Pfizer and plaintiffs' leadership signed a binding Master Settlement Agreement on July 21, 2026, expected to resolve about 80% of pending federal Depo-Provera meningioma cases.
Read more →